Stay updated on Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial

Sign up to get notified when there's something new on the Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page’s display version/revision indicator was updated from v3.5.0 to v3.5.3, reflecting a site/release stack change rather than any modification to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-26T08:22:46.000Z thumbnail image
  3. Check
    27 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Added detailed definitions for response criteria (iRECIST/RECIST) and endpoints (CR, PR, SD, PD) under Outcome Measures. Included an external resource reference (Genetic and Rare Diseases Information Center) related to head and neck cancer terminology.
    Difference
    0.8%
    Check dated 2026-03-28T13:49:47.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No user-visible changes to the Study Details page are indicated.
    Difference
    0.1%
    Check dated 2026-03-21T08:00:39.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Updated the IMPORTANCE trial entry with slow recruitment and termination status, along with a 'Results Posted' update. Added detailed study plan information and key dates.
    Difference
    3%
    Check dated 2026-03-13T22:13:45.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-06T18:31:18.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page shows a minor version update from v3.4.1 to v3.4.2; no study content or functionality changes are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:32:55.000Z thumbnail image

Stay in the know with updates to Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial page.